Dongwha's antimicrobial agent wins excellent patent technology award
Published: 2007-12-27 06:59:00
Updated: 2007-12-27 06:59:00
Donwha Pharm earned a state-of-the-art patent technology award for its novel quinolone carboxy derivative (zabofloxacin, DW224a) on December 21, following the Presidential Award in 2007 Health Industry and Technology Exhibition of Korea (HITEK) on December 6.
Zabofloxacin is a fluoroquinolone ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
